Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime

On July 25, 2025, Health Canada released its annual 2024–2025 Statistical Report for the Patented Medicines (Notice of Compliance) Regulations, Data Protection...

MT

McCarthy Tétrault LLP

Patented Medicine Prices Review Board Publishes New Guidelines For PMPRB Staff: Finally, Some Guidance For Patentees

On June 30, the Patented Medicine Prices Review Board (PMPRB) published new Guidelines for PMPRB Staff (the Guidelines) that will take effect on Jan. 1, 2026.

BL

Borden Ladner Gervais LLP

Les nouvelles lignes directrices du CEPMB sont enfin disponibles

Le 30 juin, le Conseil d'examen du prix des médicaments brevetés (le « CEPMB ») a publié les Lignes directrices pour le personnel du CEPMB...

Canada Healthcare

FF

Fasken (French)

The Court Grants An Appeal In Favour Of Psychedelic Assisted Psychotherapy – Toth v. Canada, 2025 FCA 119

A ruling from the Federal Court of Canada has resulted in an appeal of prior government refusals to permit access to psilocybin in connection with psilocybin assisted psychotherapy ("PSAP").

Canada Healthcare

ML

McMillan LLP

Patents And Prior Art: Federal Court Clarifies Standards For Anticipation And Obviousness

AB

Aird & Berlis LLP

2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Important New Procedural Guidelines From The PMPRB

AM

Aird & McBurney LP

Final Guidelines From Canada's PMPRB: The New Era Begins

TL

Torys LLP

The Trademark Four(Mula): Enforcement And Risk Mitigation

OH

Osler, Hoskin & Harcourt LLP

Q&A On Managing Intergenerational Growth In Canadian Agribusiness

Canada Real Estate

BJ

Bennett Jones LLP

July 2025 Rosen Sunshine Newsletter

Canada Government

RS

Rosen Sunshine LLP

Finalized PMPRB Guidelines Published

SB

Smart & Biggar

At Long Last: The New PMPRB Guidelines Are Here

Worldwide Healthcare

F

Fasken

CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary

Canada Healthcare

SB

Smart & Biggar

How CRA Conducts Net Worth Audits And Enforces Gross Negligence Penalties Against Canadian Taxpayers: Lessons From Mann v. The King And Other Cases

RS

Rotfleisch & Samulovitch P.C.

2025 Global In-House Counsel Report: Unique Insights Into The Global In-House Profession From ICW | Mondaq

Worldwide Law Practice

IC

In-House Counsel Worldwide

La CSC annule les plafonds liés aux dépenses de publicité politique faite par des tiers en période préélectorale en Ontario

Canada Media & IT

BC

Blake, Cassels & Graydon LLP

Remedies For Reprisal: Reinstatement And The Duty To Mitigate Under The Employment Standards Act, 2000

Canada Employment

LL

Lerners LLP

Implications Of The GENIUS Act On Stablecoins In Canada

Canada Technology

MT

Miller Thomson LLP

North Of Legal Or South Of Safe? Key Legal And Regulatory Considerations To Substantiate "Made In Canada" Claims

On the heels of Canada Day and with Canadian patriotism on the rise, many companies doing business in Canada are eager to promote their products as "Canadian".

Canada Healthcare

LS

Lenczner Slaght LLP

CDA Opens Public Consultation On Pharmacare National Formulary – Deadline July 18, 2025

On June 19, 2025, the Essential Prescription Drugs and Related Products Advisory Panel of Canada's Drug Agency ("CDA") opened a public consultation...

Canada Healthcare

F

Fasken

Health Canada's New Draft Guidance For Biosimilar Biologic Drugs

On June 10, 2025, Health Canada issued a draft of the new "Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs...

Canada Healthcare

F

Fasken

Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training

TheraPsil, a patient advocacy organization, and 73 healthcare practitioners (HCPs) have succeeded in the Federal Court of Appeal (FCA) to overturn the refusal of the Minister of Mental Health...

Canada Healthcare

SB

Smart & Biggar

Pharma, National Security And Tariffs: Where Do We Go From Here?

Canada Healthcare

BL

Borden Ladner Gervais LLP

Psychedelic Appeal: FCA Rules That Government Must Explain Policy Change On Psilocybin Access

Canada Healthcare

TL

Torys LLP

Update On Biosimilars In Canada – June 2025

Canada Healthcare

SB

Smart & Biggar

Travel Insurance And Alcohol: What Every Canadian Needs To Know

Canada Litigation

Wallace Smith LLP

La nouvelle ébauche de la Ligne directrice de Santé Canada sur les médicaments biologiques biosimilaires

Canada Healthcare

FF

Fasken (French)

Health Canada Consultation On Revised Biosimilar Guidance: No Requirement For Comparative Clinical Efficacy And Safety Trials

Canada Healthcare

SB

Smart & Biggar

Legal Services For Buying Or Selling A Convenience Store In Canada

Canada Commercial

Pacific Legal PC

Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials

Canada Healthcare

MT

McCarthy Tétrault LLP

Health Canada Proposes To Remove Phase III Trial Requirement From Biosimilar Approval Pathway

Canada Healthcare

GW

Gowling WLG

Drug And Alcohol Testing In Canada: SCC Denies Leave To Appeal In Power Workers' Union v. Canada

Canada Employment

BL

Borden Ladner Gervais LLP

Legal Services For Buying Or Selling A Convenience Store In Canada

The Canadian convenience store industry remains a profitable market for investors and business owners. Those small-sized retail shops loaded with everyday items, snacks, lottery tickets, and other high-turnover consumer...

Canada Commercial

Pacific Legal PC

Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials

Health Canada has released a draft version of an amended Guidance Document on biosimilar submission requirements (link here). In a significant reversal of policy...

Canada Healthcare

MT

McCarthy Tétrault LLP

Health Canada Proposes To Remove Phase III Trial Requirement From Biosimilar Approval Pathway

On June 10, 2025, Health Canada released a draft revision to its Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs, opening a consultation period that runs until September 8, 2025.

Canada Healthcare

GW

Gowling WLG

Drug And Alcohol Testing In Canada: SCC Denies Leave To Appeal In Power Workers' Union v. Canada

On May 29, 2025, the Supreme Court of Canada (SCC) dismissed an application for leave to appeal from the decision of the Federal Court of Appeal (FCA) upholding drug and alcohol testing requirements...

Canada Employment

BL

Borden Ladner Gervais LLP

Apotex Not Entitled To Damages For Delayed Generic Drug Launch

TS

Tierney Stauffer LLP

How Do I Get Out Of This? New Guidance On Eligibility For Tariff Remissions And Support Programs For Canadian Businesses

It has been a tumultuous spring for businesses involved in trade between Canada and the United States. This blog rounds up the latest frequently asked questions on Canada-US tariffs...

Canada International

BJ

Bennett Jones LLP

Court Of Appeal Cuts Off Speculative Product Liability Claims

In 2024, Ontario's highest court affirmed the principle that a certifiable tort claim requires a plaintiff to provide some basis in fact for a present, materialized injury that is "sufficiently serious."

Canada Litigation

BJ

Bennett Jones LLP

Government Of Ontario Tables Budget 2025: A Plan To Protect Ontario

Yesterday, Ontario Finance Minister Peter Bethlenfalvy tabled the Government of Ontario's budget, titled A Plan to Protect Ontario, in the Legislative Assembly.

Worldwide Strategy

GW

Gowling WLG

Episode 76: Scaling Impact Through Entrepreneurship In Food And Hospitality (Podcast)

Join Heather Barnhouse, Partner in our Edmonton office, as she explores women in leadership and entrepreneurship, and the ecosystem that supports them. In episode 76...

Canada Commercial

D

Dentons

Arbitrator Rejects "Lowest-Cost Generic" Policy For Generic Substitutes In Collective Bargaining Agreement

Canada Employment

C

Cassels

Court Finds Eculizumab Patent Neither Anticipated Nor Obvious

AK

Aitken Klee

Landlords May Soon Need To Be On (Top Of) Drugs: Unpacking Ontario's Bill 10

Canada Real Estate

RA

Robins Appleby LLP

Mandatory Front-of-package Labelling Compliance By 2026 — Are You Prepared?

Canada Healthcare

BL

Borden Ladner Gervais LLP

A Guide To Commercial Patriotism: Understanding 'Made In Canada' And Similar Labels

Canada Anti-trust

AB

Aird & Berlis LLP

5 Key Trends Shaping The Life Sciences Industry (Video)

Canada Healthcare

RS

RSM Canada

Licensing Partnerships In Life Sciences: Emerging And Expected Trends In 2025

Canada Healthcare

GW

Gowling WLG

Instruments médicaux basés sur l'IA — Transformation et réglementation

Canada Healthcare

MT

McCarthy Tétrault LLP

Some Things Last Forever: Government Of Canada Proposes Regulatory Measures For PFAS

Canada Environment

OH

Osler, Hoskin & Harcourt LLP

Health Canada Publishes Guide To The Precision Regulating Authorities Under The Food And Drugs Act

Canada Healthcare

SB

Smart & Biggar

Health Canada Seeks Input On New Draft Guidance For Co-packaged Drug Products

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Releases 2025 Watch List Highlighting AI Technologies In Health Care

Canada Healthcare

SB

Smart & Biggar

Exploring A Canadian Regulatory Framework For Cannabidiol (CBD)

Canada Healthcare

TL

Torys LLP

Episode 19: Advancing Superfood Innovation And Unlocking The Power Of The Haskap Berry (Podcast)

Canada Healthcare

D

Dentons

Trade War Update: Relief For Some As Canada Orders Six-Month Reprieve On Retaliatory Tariffs On A Wide Range Of Imported Goods

Canada International

MT

McCarthy Tétrault LLP

See more

Latest Videos

See more

Pricing And Reimbursement: Federal Drug Price Control

TL

Torys LLP

Nutrition Tips & Advice During COVID-19 (Video)

GW

Gowling WLG

What Are The Challenges And Opportunities In Ontario's Budding Cannabis Retail Market? (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Two: Weed Growth (Video)

D

Dentons

2018 Legal Year In Review (Video)

OH

Osler, Hoskin & Harcourt LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More